secwatch.observer — SEC 8-K summary
======================================

Issuer:     P3 Health Partners Inc. (PIII)
CIK:        0001832511
Form:       8-K
Filed at:   2023-03-15T23:59:59+00:00
Accession:  0001104659-23-032430
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

P3 Health Partners reaffirms FY2022 guidance and provides FY2023 outlook; 10-K filing delayed to March 30
--------------------------------------------------------------------------------

- Reaffirmed FY2022 revenue $1.025B-$1.075B (61%-69% YoY growth) and >100k at-risk MA members.
- FY2022 adjusted EBITDA loss reaffirmed at $118M-$128M; FY2023 adjusted EBITDA loss guided at $40M-$60M.
- Preliminary 2023 revenue guidance $1.20B-$1.25B; at-risk MA membership 115k-120k.
- Expects positive adjusted EBITDA in 2024; 10-K filing delay due to audit timing, not operational issues.
- Earnings call scheduled for March 30, 2023 after market close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832511/000110465923032430/0001104659-23-032430-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832511/000110465923032430/tm239604d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-032430

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer